West Pharmaceutical Services (WST)

West Pharmaceutical is expected to release its second-quarter earnings later this month, and analysts project a double-digit profit dip.

These three Dividend Aristocrats trade near oversold levels and offer reliable income and potential capital appreciation.

As markets get wobbly amid a lack of interest rate clarity, Goldman Sachs has called out these 5 stocks for their industry-leading balance sheet strength.

West Pharmaceutical: Q1 Earnings Snapshot

March S&P 500 E-Mini futures (ESH24) are trending up +0.21% this morning as investors looked ahead to crucial U.S. PPI data for clues on the Federal Reserve’s rate path.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.13%. Stock...

Morning Markets The S&P 500 Index ($SPX ) (SPY ) today is currently up +0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.22%. Stock...

West Pharmaceutical: Q4 Earnings Snapshot

West Pharmaceutical Services, Inc. (NYSE: (WST) ) is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The Elliott Wave structure based on the 2023 daily cycle will...